R&D Performance

CKD BiO’s fashionable R&D from fermentation to synthesis shall be continued.

2016

Developed manufacturing technology for Probiotics / Daptomycin (Antibiotic)

2015

Developed manufacturing technology for Everolimus

2014

Developed manufacturing technology for Rapamycin(Immunosuppressant)

2011

Developed manufacturing technology for Vancomycin(Antibiotic)

2010

Developed manufacturing technology for Caspofungin(Antifungal)
Designated as "Advanced Technology Center"(Ministry of Knowledge Economy, Korea)

2008

Developed manufacturing technology for Mycophenolate Mofetil(Immunosuppressant)

2005

Developed manufacturing technology for Sibutramine Malate(Medicine for weight loss)

2003

Developed manufacturing technology for Tacrolimus(Immunosuppressant)

2002

Developed manufacturing technology for Teicoplanin(Antibiotic)

2000

Developed mass production process for 7-ACA via bioconversion method

1999

Developed synthesis technology for Simvastatin(Antihyperlipidemic)
Developed diagnostic kit for Helicobacter pylori

1997

Developed manufacturing technology for Lovastatin(Antihyperlipidemic)

1994

Developed manufacturing technology for Cyclosporine(Immunosuppressant)

1993

Developed manufacturing technology for 7-ACA(Antibiotic)

1989

Developed synthesis technology for Omeprazole(Medicine for stomach ulcer)

1987

Developed synthesis technology for Cefpiramide(Antibiotic)

1984

Developed manufacturing technology for Bacampicillin(Antibiotic)

1980

Developed manufacturing technology for Rifampicin(Antituberculous)

1974

Developed manufacturing technology for Tetracycline & Oxytetracycline(Antibiotic)